ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 165 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,356 | -77.3% | 21,500 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $10,389 | -19.5% | 21,500 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $12,900 | -17.4% | 21,500 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $15,615 | -49.6% | 21,500 | 0.0% | 0.00% | -60.0% |
| Q3 2022 | $31,000 | +3.3% | 21,500 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $30,000 | +172.7% | 21,500 | 0.0% | 0.00% | +300.0% |
| Q1 2022 | $11,000 | -52.2% | 21,500 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $23,000 | -41.0% | 21,500 | 0.0% | 0.00% | -40.0% |
| Q3 2021 | $39,000 | -31.6% | 21,500 | 0.0% | 0.01% | -28.6% |
| Q2 2021 | $57,000 | -26.0% | 21,500 | 0.0% | 0.01% | -36.4% |
| Q1 2021 | $77,000 | +35.1% | 21,500 | -4.7% | 0.01% | +37.5% |
| Q4 2020 | $57,000 | 0.0% | 22,555 | 0.0% | 0.01% | -11.1% |
| Q3 2020 | $57,000 | – | 22,555 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |